4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-23-000007
Chief Executive Officer gave up 42,273 shares (to pay taxes)
- Chief Executive Officer acquired 92,778 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shea Jacqueline Elizabeth · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-26 | Exercise or conversion : show line 1 in the form | +22,544 | 99,099 | D | ||
| 2023-02-26 | Shares withheld for taxes : show line 2 in the form | −9,788 | $1.28 | $12,529 | 89,311 | D |
| 2023-02-26 | Exercise or conversion : show line 3 in the form | +70,234 | 159,545 | D | ||
| 2023-02-26 | Shares withheld for taxes : show line 4 in the form | −32,485 | $1.28 | $41,581 | 127,060 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-26 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −22,544 | 22,544 | D |
| 2023-02-26 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −70,234 | 140,466 | D |
| 2023-02-27 | Grant or award : show line 7 in the form Common Stock Option | +836,800 | 836,800 | D |
Loading xslF345X03/wf-form4_167762425136925.xml…